annual shareholders equity:
$871.96M-$178.21M(-16.97%)Summary
- As of today (August 17, 2025), NTLA annual stockholders equity is $871.96 million, with the most recent change of -$178.21 million (-16.97%) on December 31, 2024.
- During the last 3 years, NTLA annual shareholders equity has fallen by -$168.29 million (-16.18%).
- NTLA annual shareholders equity is now -29.43% below its all-time high of $1.24 billion, reached on December 31, 2022.
Performance
NTLA Shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly shareholders equity:
$715.25M-$64.66M(-8.29%)Summary
- As of today (August 17, 2025), NTLA quarterly stockholders equity is $715.25 million, with the most recent change of -$64.66 million (-8.29%) on June 30, 2025.
- Over the past year, NTLA quarterly shareholders equity has dropped by -$255.81 million (-26.34%).
- NTLA quarterly shareholders equity is now -42.11% below its all-time high of $1.24 billion, reached on December 31, 2022.
Performance
NTLA quarterly shareholders equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Shareholders equity Formula
Shareholders Equity = Total Assets − Total Liabilities
NTLA Shareholders equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.0% | -26.3% |
| 3 y3 years | -16.2% | -18.8% |
| 5 y5 years | +223.1% | +103.4% |
NTLA Shareholders equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.4% | at low | -42.1% | at low |
| 5 y | 5-year | -29.4% | +223.1% | -42.1% | +117.0% |
| alltime | all time | -29.4% | >+9999.0% | -42.1% | +3473.7% |
NTLA Shareholders equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $715.25M(-8.3%) |
| Mar 2025 | - | $779.92M(-10.6%) |
| Dec 2024 | $871.96M(-17.0%) | $871.96M(-9.4%) |
| Sep 2024 | - | $962.62M(-0.9%) |
| Jun 2024 | - | $971.06M(-6.3%) |
| Mar 2024 | - | $1.04B(-1.3%) |
| Dec 2023 | $1.05B(-15.0%) | $1.05B(+1.2%) |
| Sep 2023 | - | $1.04B(-6.1%) |
| Jun 2023 | - | $1.10B(-7.2%) |
| Mar 2023 | - | $1.19B(-3.6%) |
| Dec 2022 | $1.24B(+18.8%) | $1.24B(+49.8%) |
| Sep 2022 | - | $824.95M(-6.3%) |
| Jun 2022 | - | $880.55M(-7.7%) |
| Mar 2022 | - | $953.75M(-8.3%) |
| Dec 2021 | $1.04B(+97.4%) | $1.04B(-6.0%) |
| Sep 2021 | - | $1.11B(+123.7%) |
| Jun 2021 | - | $494.81M(-9.4%) |
| Mar 2021 | - | $545.87M(+3.6%) |
| Dec 2020 | $527.07M | $527.07M(+59.9%) |
| Sep 2020 | - | $329.62M(-6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2020 | - | $351.59M(+41.9%) |
| Mar 2020 | - | $247.76M(-8.2%) |
| Dec 2019 | $269.88M(-2.9%) | $269.88M(-2.1%) |
| Sep 2019 | - | $275.65M(-0.4%) |
| Jun 2019 | - | $276.87M(+4.7%) |
| Mar 2019 | - | $264.34M(-4.9%) |
| Dec 2018 | $277.92M(-7.5%) | $277.92M(+5.6%) |
| Sep 2018 | - | $263.27M(-5.8%) |
| Jun 2018 | - | $279.34M(-5.5%) |
| Mar 2018 | - | $295.50M(-1.7%) |
| Dec 2017 | $300.60M(+43.3%) | $300.60M(+70.9%) |
| Sep 2017 | - | $175.85M(-6.3%) |
| Jun 2017 | - | $187.59M(-6.2%) |
| Mar 2017 | - | $199.88M(-4.7%) |
| Dec 2016 | $209.84M(+211.5%) | $209.84M(-3.8%) |
| Sep 2016 | - | $218.12M(-2.4%) |
| Jun 2016 | - | $223.60M(+263.7%) |
| Mar 2016 | - | $61.48M(-390.0%) |
| Dec 2015 | $67.36M(+790.2%) | -$21.20M |
| Dec 2014 | $7.57M | - |
FAQ
- What is Intellia Therapeutics, Inc. annual stockholders equity?
- What is the all time high annual shareholders equity for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual shareholders equity year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly shareholders equity year-on-year change?
What is Intellia Therapeutics, Inc. annual stockholders equity?
The current annual shareholders equity of NTLA is $871.96M
What is the all time high annual shareholders equity for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual stockholders equity is $1.24B
What is Intellia Therapeutics, Inc. annual shareholders equity year-on-year change?
Over the past year, NTLA annual stockholders equity has changed by -$178.21M (-16.97%)
What is Intellia Therapeutics, Inc. quarterly stockholders equity?
The current quarterly shareholders equity of NTLA is $715.25M
What is the all time high quarterly shareholders equity for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly stockholders equity is $1.24B
What is Intellia Therapeutics, Inc. quarterly shareholders equity year-on-year change?
Over the past year, NTLA quarterly stockholders equity has changed by -$255.81M (-26.34%)